US and Japanese stock indexes are at all-time highs as the world adapts to President Trump's trade policy, tariffs bring in ...

The European Union could not say when a joint statement on tariffs with the United States would be ready, nor when the White House would issue an executive or ...

AbbVie to invest $195m in US API manufacturing expansion as pharma rushes to boost domestic capacity ahead of expected drug ...

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Novartis AG today and set a price target of CHF95.00. The company’s shares opened today at CHF96.08. Take advantage of TipRanks Premium ...

Novartis' mAb ianalumab helped maintain safe platelet levels for a prolonged period, reducing patient reliance on hospital ...

Novartis (NYSE:NVS) (SIX:NOVN) said its experimental antibody ianalumab, used in combination with eltrombopag, achieved the ...

Novartis drew heightened retail chatter on Monday amid reports that Swiss ministers plan to meet this week with top ...

Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...

EUROPEAN shares ticked lower on Monday, as investors refrained from making big bets ahead of an eventful week packed with ...

The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...

President Trump on Monday signed an executive order extending the tariff truce between the US and China for another 90 days, reports said, pushing trade negotiations out to the fall. Also, Nvidia ...

If approved, Novartis' ianalumab would become the first targeted treatment for patients with Sjögren’s disease.